Vitamin D status and COVID-19 severity

Area of Science:

• Nutritional Immunology
• Infectious Diseases
• Public Health

Background:

• Known risk factors for severe COVID-19 include age, BMI, and comorbidities.
• The role of vitamin D status in COVID-19 severity requires further investigation.

Purpose of the Study:

• To explore the relationship between vitamin D status and COVID-19 severity.
• To determine if vitamin D deficiency is a predictor of symptomatic coronavirus disease 2019.

Main Methods:

• A prospective, cross-sectional study enrolled 100 COVID-19 patients in Johannesburg, South Africa.
• Data collected included patient demographics, sunlight exposure, BMI, and blood levels of vitamin D, calcium, albumin, magnesium, and alkaline phosphatase.
• Patients were categorized into symptomatic (COVID-19 pneumonia) and asymptomatic groups.

Main Results:

• An 82% prevalence of vitamin D deficiency or insufficiency was observed among COVID-19 patients.
• Symptomatic patients had significantly lower vitamin D levels (18.1 ng/mL) compared to asymptomatic patients (25.9 ng/mL).
• Vitamin D deficient patients had a 2.5-fold increased risk of symptomatic COVID-19. Age and vitamin D levels were independent predictors of severity.

Conclusions:

• A high prevalence of vitamin D deficiency and insufficiency exists in hospitalized COVID-19 patients.
• Vitamin D deficiency is associated with an increased risk of developing symptomatic coronavirus disease 2019.
• Maintaining adequate vitamin D levels may be important for mitigating COVID-19 severity.